The differences between the Federal Circuit’s most-reversed and least-reversed district courts run far deeper than their success rates on appeal — a metric that can vary widely throughout the judiciary, according to Law360’s look at three years of Federal Circuit cases.
The organizers of New York’s Tribeca Film Festival have filed a trademark infringement suit against Tribeca Network LLC, arguing that its use of the word “Tribeca” in connection with its entertainment products encroaches on their intellectual property rights.
A former computer consultant for Morgan Stanley on Wednesday pled guilty to charges related to the theft of company proprietary information regarding hedge funds.
The Chicago Board Options Exchange Inc. (CBOE) has filed a declaratory judgment suit, asking a federal judge in Chicago to declare three automated exchange-related patents held by rival International Securities Exchange Inc. invalid and/or not infringed by the CBOE’s hybrid trading system.
A judge in a New Jersey patent case has reversed a magistrate judge’s order forcing a biotech company to return over 500 mistakenly disclosed confidential documents.
A U.S. jury has convicted a former Coca-Cola Co. secretary of conspiring to steal the beverage giant's trade secrets with the intention of selling them to rival PepsiCo Inc.
Online video service YouTube Inc. has agreed to take more than 100,000 video clips off its Web site after media giant Viacom Inc. said the clips violated the 1998 Digital Millennium Copyright Act.
The U.S. Court of Appeals for the Federal Circuit has shot down a doctor’s request to pursue foreign patent infringement claims in the U.S. courts.
Pharmaceutical giant GlaxoSmithKline wants a preliminary injunction banning generic drug manufacturer Ranbaxy Laboratories from launching a version of its herpes treatment in the U.S.
A licensing company for digital compression devices has targeted a California DVD player manufacturer in a lawsuit for allegedly breaking a patent portfolio license and owing millions of dollars in royalties.
Japan’s largest telecommunications company has lost a battle in its long-running patent war with the University of Texas, with a court ruling the company was not entitled to immunity from U.S. jurisdiction.
A federal jury has awarded $74.7 million to Asyst Technologies Inc., which accused rival tech company Jenoptik AG of infringing the patent on its Smart Traveler system.
Google Inc. failed on Thursday to secure a pan-European trademark for its free Internet e-mail service “Gmail” after the European Union’s trademark authority rejected an appeal.
Bridgestone/Firestone North American Tire LLC is hoping to put the brakes on GPX International Tire Corporation’s sale of off-road tires, filing a suit against the work tire company Wednesday for alleged trademark infringement, unfair competition and false advertising.
Biotechnology company Nucleonics Inc. said Thursday that the U.S. Patent and Trademark Office has rejected the remaining claims of rival Benitec’s patent on gene silencing technologies.
Medical device maker Medtronic Inc. on Monday sued a rival cardiovascular device manufacturer for allegedly infringing its patents relating to blood vessel occlusion devices made with alloys.
Delaying their battle over the iPhone trademark, Apple Inc. and Cisco Systems Inc. have agreed Apple will have more time to respond to Cisco's infringement lawsuit so the pair can mull over trademark rights and interoperability.
A Honolulu, Hawaii-based company went on the legal warpath Wednesday, filing two patent infringement suits against defendants including Time Warner Inc., Comcast Cable Communications LLC and Samsung Telecommunications America LP over cell phones and cable modems.
Two rival semiconductor design software companies both declared victory on Wednesday, after a judge ruled that Synopsys Inc. and International Business Machines Corp. co-own two of the three patents in dispute.
A bill was reintroduced in the U.S. Senate Tuesday that would prohibit brand name drug makers from marketing generic versions of their own drugs, a move senators said would improve consumer access to lower-priced drugs.
In yet another setback for Dutch drug maker Synthon Pharmaceuticals Inc., a U.S. judge has agreed with defendant Pfizer Inc. that Synthon’s patent for generic Norvasc was gleaned through inequitable conduct.